Ethicon is expanding the April 2014 global commercial suspension and initiating a worldwide voluntary market withdrawal of all Ethicon Morcellation devices, including generators and disposables that currently remain in the market. The risk-benefit assessment associated with the use of these devices in hysterectomy and myomectomy procedures for removing fibroids remains uncertain.